In October 2024, Novartis announced that based on its review of 48-week data from the Phase 3 MANIFEST-2 study, longer follow-up time is needed to determine the regulatory path for pelabresib in ...

Cincinnati Financial Corporation (Nasdaq: CINF) today reported: Fourth-quarter 2024 net income of $405 million, or $2.56 ...

Mattel continues to harvest gains from its turnaround, delivering above breakeven operating margins starting in 2019 and reaching 13.7% in 2024. Despite the outlook for modestly positive sales growth, ...

With approximately 95% of its revenue from the defense sector, Saab is well positioned to capitalize on the expected increase in European defense budgets to at least 2% of GDP due to the ...

On February 6, 2025, the SEC announced that it was providing a temporary exemption from compliance with Rule 13f-2 under the ...